477 related articles for article (PubMed ID: 16965874)
1. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
4. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.
Berry DP; Clarke P; Hardcastle JD; Vellacott KD
Br J Surg; 1997 Sep; 84(9):1274-6. PubMed ID: 9313712
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
[TBL] [Abstract][Full Text] [Related]
8. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial.
Federici A; Giorgi Rossi P; Borgia P; Bartolozzi F; Farchi S; Gausticchi G
J Med Screen; 2005; 12(2):83-8. PubMed ID: 15949119
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
[TBL] [Abstract][Full Text] [Related]
10. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening.
Bretthauer M
J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
[TBL] [Abstract][Full Text] [Related]
12. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
[TBL] [Abstract][Full Text] [Related]
13. Screening for colorectal cancer: flexible sigmoidoscopy and faecal occult blood immunochemical testing. Which test is superior?
Castiglione G
Gut; 2010 Jan; 59(1):9-10. PubMed ID: 20007956
[No Abstract] [Full Text] [Related]
14. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
16. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
[TBL] [Abstract][Full Text] [Related]
17. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
Stern C
Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
[TBL] [Abstract][Full Text] [Related]
18. Attempting the improbable: offering colorectal cancer screening to all appropriate patients.
Bejes C; Marvel MK
Fam Pract Res J; 1992 Mar; 12(1):83-90. PubMed ID: 1549951
[TBL] [Abstract][Full Text] [Related]
19. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer screening by obstetrician-gynecologists.
Musinski SE
Am J Obstet Gynecol; 2001 May; 184(6):1054-6. PubMed ID: 11349154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
